Anu Wallecha

发表

Episomal Expression of Truncated Listeriolysin O in LmddA-LLO–E7 Vaccine Enhances Antitumor Efficacy by Preferentially Inducing Expansions of CD4+FoxP3− and CD8+ T Cells

J. Berzofsky, L. Ozbun, S. Khleif, 2014, Cancer Immunology Research.

Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy

S. Khleif, R. Abu Eid, M. Mkrtichyan, 2013, Journal of Immunotherapy for Cancer.

Dam- and OxyR-Dependent Phase Variation of agn43: Essential Elements and Evidence for a New Role of DNA Methylation

M. W. van der Woude, A. Wallecha, Vincent Munster, 2002, Journal of bacteriology.

Listeria monocytogenes-Derived Listeriolysin O Has Pathogen-Associated Molecular Pattern-Like Properties Independent of Its Hemolytic Ability

P. Maciag, V. Shahabi, A. Wallecha, 2012, Clinical and Vaccine Immunology.

Listeria-derived Listeriolysin O has PAMP-like properties independent

P. Maciag, V. Shahabi, A. Wallecha, 2012 .

Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer

R. Hannan, C. Guha, A. Alfieri, 2012, Cancer Immunology, Immunotherapy.

Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy

P. Maciag, V. Shahabi, A. Wallecha, 2008, Clinical and Vaccine Immunology.

Development of a Listeria monocytogenes based vaccine against prostate cancer

P. Maciag, V. Shahabi, A. Wallecha, 2008, Cancer Immunology, Immunotherapy.

Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.

P. Maciag, V. Shahabi, A. Wallecha, 2009, Advances in applied microbiology.

Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma

A. Wallecha, Y. Paterson, M. Huebner, 2016, Clinical Cancer Research.

Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment

P. Maciag, V. Shahabi, A. Wallecha, 2010, Bioengineered bugs.

The Use of Living Listeria Monocytogenes as an Active Immunotherapy for the Treatment of Cancer

P. Maciag, V. Shahabi, J. Rothman, 2010 .

Purification and characterization of two beta-glucosidases from a thermo-tolerant yeast Pichia etchellsii.

Saroj K. Mishra, A. Wallecha, S. Mishra, 2003, Biochimica et biophysica acta.

Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human

P. Maciag, V. Shahabi, M. Seavey, 2011, Cancer Gene Therapy.

Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.

S. Hussain, D. Sewell, A. Wallecha, 2007, Cancer immunity.

A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors

P. Maciag, V. Shahabi, M. Seavey, 2009, Clinical Cancer Research.

A One Health overview, facilitating advances in comparative medicine and translational research

Dongsheng Duan, Ubadah Sabbagh, James P. Calvet, 2016, Clinical and Translational Medicine.

Biomarker identification in serum samples from patients with recurrent cervical cancer treated with ADXS11-001 immunotherapy

P. Molli, A. Wallecha, I. Malinina, 2013, Journal of Immunotherapy for Cancer.

Cancer immunotherapy using recombinant Listeria monocytogenes: Transition from bench to clinic

A. Wallecha, Reshma Singh, Anu Wallecha, 2011, Human vaccines.

Listeria monocytogenes

Ashley M. Sherrid, T. Kollmann, Zach Liang, 2014, Human vaccines & immunotherapeutics.

Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human

P. Maciag, V. Shahabi, M. Seavey, 2011, Cancer Gene Therapy.

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

J. Rothman, A. Wallecha, C. French, 2012, Journal of oncology.

Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment

A. Wallecha, I. Malinina, Reshma Singh, 2013, Journal of Immunotherapy for Cancer.

Control of Gene Expression at a Bacterial Leader RNA, the agn43 Gene Encoding Outer Membrane Protein Ag43 of Escherichia coli

P. Dehaseth, M. W. van der Woude, A. Wallecha, 2014, Journal of bacteriology.

Phase Variation of Ag43 Is Independent of the Oxidation State of OxyR

M. W. van der Woude, A. Wallecha, Vincent Munster, 2002, Journal of bacteriology.